Navigation Links
Varian Medical Systems Establishes Radiotherapy Training Center and Clinical Help Desk in Tokyo, Japan
Date:1/11/2012

TOKYO, Jan. 11, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), a world leader in radiotherapy equipment and software for the treatment of cancer, has established its first education center in Tokyo, Japan, to train radiation oncologists, medical physicists, and technologists who work with Varian's cancer treatment systems. In addition, the company has established a clinical contact center (Help Desk), to provide phone support for Varian's customers in Japan.

These services are housed in a new facility that is conveniently located in central Tokyo.  The training center will begin offering courses to radiation oncology clinical professionals in February 2012.  It features a computer-equipped classroom with 20 work stations and state of the art audio/visual equipment, as well as two customer lounges. 

"Radiotherapy is widely recognized as an efficient treatment for cancer.  The number of cancer patients who received radiotherapy treatments in Japan doubled over the last decade, rising from roughly 100,000 per year in the late 1990s to over 250,000 today," said Makoto Yamada, sales manager for Varian in Japan, citing statistics that have been published by the Japanese Society for Therapeutic Radiology and Oncology (JASTRO).  "JASTRO predicts that the number of Japanese people needing access to radiotherapy services will rise to 360,000 by 2015.  But there is a shortage of trained clinical professionals in Japan.  Varian's new education center represents our commitment to helping address the expanding need for training in this area." 

The field of radiation oncology has evolved over the last decade, and now requires the skillful use of complex technology that enables doctors to precisely target tumors while minimizing exposure of surrounding healthy tissues.  "Varian's training center will help clinicians develop the skills for using Varian technology to deliver advanced treatments like intensity-modulated radiotherapy, image-guided radiotherapy, and stereotactic radiosurgery," Mr. Yamada said. "The new Help Desk will then provide them with phone and e-mail support, whenever questions come up as they use Varian technology to treat patients."

"The addition of a dedicated Help Desk service is in keeping with Varian's commitment to expanding our support for the clinical oncology community of Japan," added Jon Hollon, Varian's director of worldwide training and education.  "Whereas in the past customers needing assistance sometimes had to wait for a return call from an applications specialist, they now can access a dedicated team of highly trained product experts during local business hours."

Varian's new offices are located at 5-1 Kabutocho Nihonhashi, Chuo-ku, Tokyo.  The first class scheduled in the new training center will take place in February, and will focus on Varian's Eclipse™ treatment planning software.  Additional courses are scheduled for March, April, and May, covering Eclipse operations plus the ARIA® oncology information system for managing cancer treatments.

"In the future, we will work with our clinical partners in Japan to develop courses on quality assurance procedures, safety, and the newest clinical modalities," Mr. Hollon said.  "Radiotherapy use is on the rise in Japan, and our goal is to provide world-class education and customer support on a local basis.  The new training center in Tokyo will help us customize our services to the specific needs of Japanese clinicians, and enable them to obtain training without leaving the country."

The Tokyo project is the sixth such education and training center established by Varian globally, following similar initiatives in Las Vegas (USA), Beijing (China), Zug (Switzerland), Buc (France), and Mumbai (India).

ABOUT VARIAN MEDICAL SYSTEMS
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.

 FOR INFORMATION CONTACT: United States

JapanMeryl Ginsberg, (650) 424-6444

Tsuneo Kobayashi, +81.3.4486.5040meryl.ginsberg@varian.com

tsuneo.kobayashi@varian.comNote to editors: photos available at the following URL: click here.

 


'/>"/>
SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):